Investing With IBD cover image

Ep. 213 Matt Caruso: Knowing Your Tools For Success

Investing With IBD

CHAPTER

The Computer Software Enterprise: A New Growth Story

There are already three funds in VSCO, Harvard disruptive innovation fund is in this and VSCO fidelity contra one. I think that is pretty impressive for a company that came out public in the last couple of years. It's got great price and volume characteristics a great thematic that's on management has a sizable position at 10% so they're going to want to get the share prices moving too. So I could see is being as one of the leaders if this market does get up into gear. The sales numbers are pretty good. You know I mean really really strong double digit growth there. Earnings it's it's not it's not profitable quite yet.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner